Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus: inactive carriers.

Sanjeev Kumar Sharma1, Nitin Saini, Yogesh Chwla

  • 1Department of Hepatology, PGIMER, Chandigarh, 160012, India. sanju_pgi@hotmail.com

Virology Journal
|September 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ce-Doped SnO<sub>2</sub> Nanoparticles for Efficient Photocatalytic Degradation of Organic Dyes and Antibiotics Under Sunlight Exposure.

ChemPlusChem·2026
Same author

Noble metal-TMO-carbon hybrid catalysts for solar-driven antibiotic detoxification in wastewater.

Chemical communications (Cambridge, England)·2026
Same author

Interfacial V<sup>5+</sup>/V<sup>4+</sup> Redox Kinetics Enabling Fe-free Photo-Fenton Catalysis in α-V<sub>2</sub>O<sub>5</sub>-ACNT Nanohybrids for Efficient Removal of Mixed CBZ and DFN.

ACS applied materials & interfaces·2026
Same author

Hierarchical Plasmonic Au@ZnO Chemosensor Enhanced the Sensitivity and Detection Limit of Pb<sup>2+</sup> Metallic Ions.

ACS omega·2026
Same author

Assessment of physicochemical, microbiological, and quality characteristics of raw standardized milk in northern parts of India.

Journal of dairy science·2025
Same author

Nanosponges for Chemosensors and Biosensors: Next Generation Functional Materials.

Chemistry, an Asian journal·2025
Same journal

Molecular characterization and phylogenetic analysis of foot-and-mouth disease virus in Nigeria.

Virology journal·2026
Same journal

Genomic insights into influenza A(H1N1)pdm09 virus evolution in Yunnan province, China, during 2018-2023.

Virology journal·2026
Same journal

Serotypes distribution characteristic of enterovirus in sewage in Hangzhou, Zhejiang Province from January 2023 to December 2024.

Virology journal·2026
Same journal

Viral metagenomic analysis of the blood virome in patients with multiple autoimmune diseases.

Virology journal·2026
Same journal

A yellow fever 17D and Usutu virus chimera with rationally designed mutations in the envelope protein is lethal in an Ifnar<sup>-/-</sup> mouse model.

Virology journal·2026
Same journal

Inhibition of calpain-mediated BAX cleavage attenuates Japanese encephalitis virus-induced apoptosis in SH-SY5Y neuroblastoma cells.

Virology journal·2026
See all related articles

The inactive Hepatitis B surface antigen (HBsAg) carrier state, common in chronic HBV infection, generally has a good prognosis. However, a significant percentage may experience reactivation, risking liver damage.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Inactive carriers represent the largest demographic among chronic Hepatitis B virus (HBV) infected individuals, estimated at 300 million globally.
  • The inactive HBsAg carrier state is characterized by the absence of HBeAg, presence of anti-HBe, undetectable or low HBV DNA levels, normal ALT, and minimal liver histology changes.

Purpose of the Study:

  • To summarize the clinical characteristics, prognosis, and potential risks associated with the inactive Hepatitis B surface antigen (HBsAg) carrier state.
  • To highlight the long-term outcomes and monitoring considerations for individuals in this phase of chronic HBV infection.

Main Methods:

  • Review of long-term follow-up data (up to 18 years) of patients in the inactive HBsAg carrier state.
  • Analysis of diagnostic criteria including serological markers (HBeAg, anti-HBe), HBV DNA levels, ALT levels, and liver biopsy findings.

Related Experiment Videos

  • Assessment of the incidence of spontaneous reactivation and associated liver disease progression.

    • Main Results:

    • The majority of inactive HBsAg carriers exhibit sustained biochemical remission with a low risk of cirrhosis and hepatocellular carcinoma (HCC).
    • Approximately 20-30% of inactive carriers may experience spontaneous reactivation of hepatitis B during follow-up.
    • Liver cancer can rarely develop even in non-cirrhotic inactive carriers, and reactivation can lead to progressive hepatic damage or decompensation.

    Conclusions:

    • The inactive HBsAg carrier state typically carries a benign prognosis, but requires ongoing monitoring due to the risk of reactivation.
    • Spontaneous reactivation poses a significant risk for progressive liver disease, emphasizing the need for vigilance in managing these patients.
    • While rare, the possibility of HCC development in inactive carriers underscores the importance of long-term surveillance.